Traditional medicine is a centuries-old practice and belief system across cultures that typically takes a holistic approach ...

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...

New research suggests Sonoran Desert toads went into steep decline after stories of their mind-bending chemical properties ...

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable depression. The HHS and FDA voice support for psychedelics.

GH Research (NASDAQ:GHRS) is one of the best-performing NASDAQ stocks according to analysts. On June 20, GH Research announced that it had submitted a complete response to the US FDA regarding the ...

BPL-003 is Beckley Psytech’s patent-protected intranasal formulation of mebufotenin (5-MeO-DMT) benzoate, which is administered via a previously approved nasal spray device. The study enrolled 193 ...

But 5-MeO-DMT research is progressing, currently being tested by British psychedelic drug developer Beckley Psytech and atai Life Sciences as treatment for depression, alcohol use disorder, and ...

Kahi Kamaliʻi Infant Toddler Center teacher Tiana Hema, whose patience soothes meltdowns and energy ignites creativity and play, was named Maui Economic Opportunity Employee of the Month.

The Beckley drug, BPL-003, is a nasal spray version of the psychedelic 5-MeO-DMT, a close relation to DMT and other similar psychedelics. A long list of biotechs have been looking toward psychedelic ...

The joining of psychedelic specialists Beckley Psytech Ltd. and Atai Life Sciences can now go ahead after the pair announced positive top-line results from the phase IIb study of BPL-003, an ...